Do Cancer Researchers Disclose Clinical Trial Funding?

September 5, 2018

Cancer researchers are not disclosing all their speaking fees and stock payments from drug companies, a new study finds, raising the issue of potential bias in studies the Food and Drug Administration (FDA) uses to approve new drugs.

Related Stories